MBX Biosciences, Inc. Common Stock (MBX) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 4 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for MBX is $55.33, representing a +68.6% upside from the current price of $32.81. Price targets range from a low of $18.00 to a high of $88.00.
